Recombinant multi-species AANAT protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine AANAT protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene belongs to the acetyltransferase superfamily. It is the penultimate enzyme in melatonin synthesis and controls the night/day rhythm in melatonin production in the vertebrate pineal gland. Melatonin is essential for the function of the circadian clock that influences activity and sleep. This enzyme is regulated by cAMP-dependent phosphorylation that promotes its interaction with 14-3-3 proteins and thus protects the enzyme against proteasomal degradation. This gene may contribute to numerous genetic diseases such as delayed sleep phase syndrome. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2009]
The Alternative Names of target: AA-NAT,AANAT,Aanat,Aralkylamine N-acetyltransferase (AA-NAT),DSPS,Nat-2,Nat4,SNAT,Serotonin N-acetyltransferase,Serotonin acetylase,Snat
Go
to AANAT products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-SE1491-Ag-1/ GM-Tg-hg-SE1491-Ag-2 | Human AANAT protein | Human |
| GM-Tg-rg-SE1491-Ag-1/ GM-Tg-rg-SE1491-Ag-2 | Rat AANAT protein | Rat |
| GM-Tg-mg-SE1491-Ag-1/ GM-Tg-mg-SE1491-Ag-2 | Mouse AANAT protein | Mouse |
| GM-Tg-cynog-SE1491-Ag-1/ GM-Tg-cynog-SE1491-Ag-2 | Cynomolgus/Rhesus macaque AANAT protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-SE1491-Ag-1/ GM-Tg-felg-SE1491-Ag-2 | Feline AANAT protein | Feline |
| GM-Tg-cang-SE1491-Ag-1/ GM-Tg-cang-SE1491-Ag-2 | Canine AANAT protein | Canine |
| GM-Tg-bovg-SE1491-Ag-1/ GM-Tg-bovg-SE1491-Ag-2 | Bovine AANAT protein | Bovine |
| GM-Tg-equg-SE1491-Ag-1/ GM-Tg-equg-SE1491-Ag-2 | Equine AANAT protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-SE1491-Ag-1/ GM-Tg-hg-SE1491-Ag-2;
GM-Tg-rg-SE1491-Ag-1/ GM-Tg-rg-SE1491-Ag-2;
GM-Tg-mg-SE1491-Ag-1/ GM-Tg-mg-SE1491-Ag-2; GM-Tg-cynog-SE1491-Ag-1/ GM-Tg-cynog-SE1491-Ag-2; GM-Tg-felg-SE1491-Ag-1/ GM-Tg-felg-SE1491-Ag-2; GM-Tg-cang-SE1491-Ag-1/ GM-Tg-cang-SE1491-Ag-2; GM-Tg-bovg-SE1491-Ag-1/ GM-Tg-bovg-SE1491-Ag-2; GM-Tg-equg-SE1491-Ag-1/ GM-Tg-equg-SE1491-Ag-2 |
| Products Name | AANAT protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | AANAT |
| Protein Sub-location | Secreted Protein/Potential Cytokines |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine AANAT protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.